Valhalla Med School Gets $1.6M To Develop Flu Vaccines

VALHALLA, N.Y. -- New York Medical College of Valhalla has received a $1.6 million contract from the Biomedical Advanced Research and Development Authority for research to develop new influenza vaccines, U.S. Rep. Nita Lowey announced in a statement Tuesday.

New York Medical College in Valhalla will research flu vaccines after receiving a $1.6 million contract from the government.
Photo Credit: *New York Medical College Facebook page*

by Eric Gendron

05/15/2014 4:00 a.m.

The Biomedical Advanced Research and Development Authority is the federal program that facilitates the development of vaccines, drugs, therapies and diagnostic tools for public health emergencies.

The influenza vaccine development project led by Dr. Doris Bucher at New York Medical College seeks to "develop influenza vaccine seed strains optimized for high-production yields and high immunogenicity," according to a statement.

“As the senior Democrat on the House Appropriations Committee, my highest priority is investing in initiatives that sustain a high quality of life for families in the Lower Hudson Valley,” Lowey said in a statement. “This particular investment seeks to expedite and enlarge flu vaccine production, so that more and better vaccines are available quicker during high demand. This is a winning formula for strong communities, and I will continue my work in Congress to ensure support for scientific research.”

Click here to follow Daily Voice Mount Pleasant and receive free news updates.